We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
IP
151
Isthmus Partners
Wisconsin
$5.89M -$71.4K -938 -1%
Retirement Systems of Alabama
152
Retirement Systems of Alabama
Alabama
$5.87M -$25.6K -336 -0.5%
LS
153
Livforsakringsbolaget Skandia
Sweden
$5.85M – – –
AAM
154
Auxier Asset Management
Oregon
$5.7M – – –
TFA
155
Toth Financial Advisory
Virginia
$5.51M +$130K +1,710 +3%
DekaBank Deutsche Girozentrale
156
DekaBank Deutsche Girozentrale
Germany
$5.42M +$3.56M +46,800 +226%
VRS
157
Virginia Retirement Systems
Virginia
$5.4M +$5.05M +66,300 New
HVC
158
Healthcare Value Capital
New Jersey
$5.39M – – –
AP
159
AHL Partners
United Kingdom
$5.36M +$4.16M +54,648 +488%
FA
160
Financial Advantage
Maryland
$5.36M +$1.75K +23 +0%
Susquehanna International Group
161
Susquehanna International Group
Pennsylvania
$5.29M +$3.29M +43,248 +199%
WG
162
Winton Group
United Kingdom
$5.29M -$14.7M -192,445 -75%
ACC
163
Accident Compensation Corp
New Zealand
$5.26M -$335K -4,400 -6%
AIG
164
American International Group
New York
$5.24M -$101K -1,323 -2%
Robeco Institutional Asset Management
165
Robeco Institutional Asset Management
Netherlands
$5.04M +$591K +7,756 +14%
SAM
166
Shell Asset Management
Netherlands
$5.02M +$182K +2,391 +4%
Stifel Financial
167
Stifel Financial
Missouri
$4.89M -$1.27M -16,639 -22%
Korea Investment Corp
168
Korea Investment Corp
South Korea
$4.77M -$3.44M -45,200 -44%
NEI
169
Northwest & Ethical Investments
Ontario, Canada
$4.72M -$167K -2,196 -4%
PIA
170
Piedmont Investment Advisors
North Carolina
$4.71M +$207K +2,724 +5%
OAC
171
OMERS Administration Corp
Ontario, Canada
$4.7M +$4.39M +57,700 New
OC
172
Oppenheimer & Co
New York
$4.63M -$333K -4,377 -7%
Ohio Public Employees Retirement System (OPERS)
173
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.57M +$1.68M +22,058 +65%
Natixis Advisors
174
Natixis Advisors
Massachusetts
$4.53M -$183K -2,404 -4%
BA
175
Boston Advisors
Massachusetts
$4.48M +$157K +2,063 +4%
5 6
7
8 9

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.